The results of the present study are also consistent with a meta-analysis of sixty-seven studies in 19,760 COVID-19 patients (6,141 with severe disease or poor outcome) reported by Paliogiannis and co-workers that lower serum albumin concentrations were significantly associated with disease severity and adverse outcomes in COVID-19 patients [20]. The gene discussed is ALB; the disease is COVID-19.